Transcend Capital Advisors LLC Has $2.96 Million Stock Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Transcend Capital Advisors LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 31.2% during the fourth quarter, Holdings Channel reports. The firm owned 5,856 shares of the healthcare conglomerate’s stock after selling 2,658 shares during the quarter. Transcend Capital Advisors LLC’s holdings in UnitedHealth Group were worth $2,962,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. International Assets Investment Management LLC increased its holdings in UnitedHealth Group by 78,814.4% during the 3rd quarter. International Assets Investment Management LLC now owns 5,296,737 shares of the healthcare conglomerate’s stock worth $3,096,896,000 after purchasing an additional 5,290,025 shares in the last quarter. Accredited Investors Inc. increased its holdings in UnitedHealth Group by 9,235.4% during the 3rd quarter. Accredited Investors Inc. now owns 784,924 shares of the healthcare conglomerate’s stock worth $458,929,000 after purchasing an additional 776,516 shares in the last quarter. Caisse DE Depot ET Placement DU Quebec increased its holdings in UnitedHealth Group by 129.7% during the 3rd quarter. Caisse DE Depot ET Placement DU Quebec now owns 1,029,540 shares of the healthcare conglomerate’s stock worth $601,951,000 after purchasing an additional 581,324 shares in the last quarter. State Street Corp increased its holdings in UnitedHealth Group by 1.3% during the 3rd quarter. State Street Corp now owns 45,540,102 shares of the healthcare conglomerate’s stock worth $26,626,387,000 after purchasing an additional 563,554 shares in the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG bought a new stake in UnitedHealth Group during the 3rd quarter worth approximately $276,785,000. 87.86% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms have recently issued reports on UNH. Wells Fargo & Company reduced their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating for the company in a report on Tuesday, January 28th. Deutsche Bank Aktiengesellschaft upped their target price on UnitedHealth Group from $595.00 to $625.00 and gave the company a “buy” rating in a report on Tuesday, December 3rd. Cantor Fitzgerald reaffirmed an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Oppenheimer upped their target price on UnitedHealth Group from $610.00 to $640.00 and gave the company an “outperform” rating in a report on Friday, December 6th. Finally, Piper Sandler dropped their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a research note on Thursday, January 2nd. One equities research analyst has rated the stock with a hold rating, twenty have given a buy rating and two have given a strong buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Buy” and a consensus price target of $629.32.

UnitedHealth Group Trading Down 1.6 %

NYSE:UNH opened at $503.01 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.83 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1 year low of $436.38 and a 1 year high of $630.73. The company has a market cap of $462.91 billion, a P/E ratio of 32.45, a P/E/G ratio of 1.40 and a beta of 0.61. The stock’s fifty day moving average price is $520.37 and its two-hundred day moving average price is $561.26.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the business posted $5.83 earnings per share. The firm’s revenue was up 6.8% compared to the same quarter last year. As a group, analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn bought 1,000 shares of UnitedHealth Group stock in a transaction that occurred on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares in the company, valued at $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.